United States Federal Circuit

Order granting plaintiff's motion for a preliminary injunction against defendants, generic drug manufacturers, is affirmed where the district court did not err in its claim construction, and did not abuse its discretion in determining that infringement is likely and that the harm and public interest favors the injunction.

Appellate Information

• Decided 11/22/2005
• Published 11/22/2005

Judges

• PROST, Circuit Judge., Before NEWMAN, RADER, and PROST, Circuit Judges.

Court

• United States Federal Circuit

Counsel

• For Appellees:
  
• Joseph M. O'Malley, Jr., Fitzpatrick, Cella, Harper & Scinto, of New York, New York, argued for plaintiffs-appellees.   With him on the brief were Bruce M. Wexler, Christopher L. Limpus, and John C. Heuton.   Of counsel was Herbert W. Rea., William R. Zimmerman, Knobbe, Martens, Olson & Bear, LLP, of Irvine, California, argued for defendants-appellants.   With him on the brief for Ranbaxy Pharmaceuticals, Inc. were Darrell L. Olson, James F. Lesniak, Craig S. Summers, Payson J. LeMeilleur, and Christy G. Lea. Of counsel on the brief were David M. Hashmall and Dominique T. Hussey, Goodwin Procter LLP, of New York, New York, for Teva Pharmaceuticals USA, Inc.